{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:02:13Z","timestamp":1771002133230,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T00:00:00Z","timestamp":1541462400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1038\/s41440-018-0126-1","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T07:13:46Z","timestamp":1541488426000},"page":"40-51","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Predictors of confirmatory test results for the diagnosis of primary hyperaldosteronism in hypertensive patients with an aldosterone-to-renin ratio greater than 20. The SHRIMP study"],"prefix":"10.1038","volume":"42","author":[{"given":"Ryuji","family":"Okamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Uraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eitaro","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,6]]},"reference":[{"key":"126_CR1","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"JW Funder","year":"2008","unstructured":"Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser, et al. Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:3266\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"126_CR2","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005;45:1243\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"126_CR3","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101:1889\u201316.","journal-title":"J Clin Endocrinol Metab"},{"key":"126_CR4","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol. 2017;69:1811\u201320.","journal-title":"J Am Coll Cardiol"},{"key":"126_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/hr.2013.80","volume":"37","author":"K Shimamoto","year":"2014","unstructured":"Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the management of hypertension (JSH 2014). Hypertens Res. 2014;37:253\u2013390.","journal-title":"Hypertens Res"},{"key":"126_CR6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","volume":"58","author":"T Nishikawa","year":"2011","unstructured":"Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, et al. Task Force Committee on Primary Aldosteronism, The Japan Endocrine Society. Guidelines for the diagnosis and treatment of primary aldosteronism\u2014the Japan Endocrine Society 2009. Endocr J. 2011;58:711\u201321.","journal-title":"Endocr J"},{"key":"126_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.cjca.2016.02.066","volume":"32","author":"AA Leung","year":"2016","unstructured":"Leung AA, Nerenberg K, Daskalopoulou SS, McBrien K, Zarnke KB, Dasgupta K, et al. Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol. 2016;32:569\u201388.","journal-title":"Can J Cardiol"},{"key":"126_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ando.2016.01.007","volume":"77","author":"Y Reznik","year":"2016","unstructured":"Reznik Y, Amar L, Tabarin A. SFE\/SFHTA\/AFCE consensus on primary aldosteronism, part 3: Confirmatory testing. Ann Endocrinol (Paris). 2016;77:202\u20137.","journal-title":"Ann Endocrinol (Paris)"},{"key":"126_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12882-015-0040-6","volume":"16","author":"M Tanimura","year":"2015","unstructured":"Tanimura M, Dohi K, Matsuda M, Sato Y, Sugiura E, Kumagai N, et al. Renal resistive index as an indicator of the presence and severity of anemia and its future development in patients with hypertension. BMC Nephrol. 2015;16:45.","journal-title":"BMC Nephrol"},{"key":"126_CR10","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/j.1464-5491.2007.02289.x","volume":"24","author":"K Matsumoto","year":"2007","unstructured":"Matsumoto K, Yano Y, Gabazza EC, Araki R, Bruno NE, Suematsu M, et al. Inverse correlation between activated protein C generation and carotid atherosclerosis in Type 2 diabetic patients. Diabet Med. 2007;24:1322\u20138.","journal-title":"Diabet Med"},{"key":"126_CR11","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1161\/CIRCULATIONAHA.107.189420","volume":"118","author":"VK Somers","year":"2008","unstructured":"Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, et al. Sleep apnea and cardiovascular disease: an American Heart Association\/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation . 2008;118:1080\u2013111.","journal-title":"Circulation"},{"key":"126_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s12471-011-0202-5","volume":"21","author":"JJ Kandhai-Ragunath","year":"2013","unstructured":"Kandhai-Ragunath JJ, Jorstad HT, de Man FH, Peters RJ, von Birgelen C. Approaches for non-invasive assessment of endothelial function: focus on peripheral arterial tonometry. Neth Heart J. 2013;21:214\u20138.","journal-title":"Neth Heart J"},{"key":"126_CR13","doi-asserted-by":"publisher","first-page":"e003629","DOI":"10.1161\/CIRCEP.115.003629","volume":"9","author":"AL Aro","year":"2016","unstructured":"Aro AL, Chugh SS. Clinical diagnosis of electrical versus anatomic left ventricular hypertrophy: prognostic and therapeutic implications. Circ Arrhythm Electrophysiol. 2016;9:e003629.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"126_CR14","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jacc.2006.08.050","volume":"49","author":"V Melenovsky","year":"2007","unstructured":"Melenovsky V, Borlaug BA, Rosen B, Hay I, Ferruci L, Morell CH, et al. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling\/dysfunction. J Am Coll Cardiol. 2007;49:198\u2013207.","journal-title":"J Am Coll Cardiol"},{"key":"126_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/hr.2016.127","volume":"40","author":"Y Yang","year":"2017","unstructured":"Yang Y, Zhu LM, Xu JZ, Tang XF, Gao PJ. Comparison of left ventricular structure and function in primary aldosteronism and essential hypertension by echocardiography. Hypertens Res. 2017;40:243\u201350.","journal-title":"Hypertens Res"},{"key":"126_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","volume":"62","author":"S Savard","year":"2013","unstructured":"Savard S, Amar L, Plouin PF, Steichen O. Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension. 2013;62:331\u20136.","journal-title":"Hypertension"},{"key":"126_CR17","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3109\/10641969909060993","volume":"21","author":"LM Ruilope","year":"1999","unstructured":"Ruilope LM, Rodicio JL. Renal surrogates in essential hypertension. Clin Exp Hypertens. 1999;21:609\u201314.","journal-title":"Clin Exp Hypertens"},{"key":"126_CR18","doi-asserted-by":"crossref","unstructured":"Bolignano D, Palmer SC, Navaneethan SD, Strippoli GF. Aldosterone antagonists for preventing the progression of chronic kidney disease. Cochrane Database Syst Rev. 2014;4:CD007004.","DOI":"10.1002\/14651858.CD007004.pub3"},{"key":"126_CR19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000442445","volume":"3","author":"N Cauwenberghs","year":"2016","unstructured":"Cauwenberghs N, Kuznetsova T. Determinants and prognostic significance of the renal resistive index. Pulse (Basel). 2016;3:172\u20138.","journal-title":"Pulse (Basel)"},{"key":"126_CR20","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1161\/HYPERTENSIONAHA.112.196717","volume":"60","author":"Y Doi","year":"2012","unstructured":"Doi Y, Iwashima Y, Yoshihara F, Kamide K, Hayashi S, Kubota Y, et al. Renal resistive index and cardiovascular and renal outcomes in essential hypertension. Hypertension. 2012;60:770\u20137.","journal-title":"Hypertension"},{"key":"126_CR21","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1152\/physrev.00026.2015","volume":"96","author":"M Stowasser","year":"2016","unstructured":"Stowasser M, Gordon RD. Primary aldosteronism: changing definitions and new concepts of physiology and pathophysiology both inside and outside the kidney. Physiol Rev. 2016;96:1327\u201384.","journal-title":"Physiol Rev"},{"key":"126_CR22","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1161\/HYPERTENSIONAHA.115.05924","volume":"67","author":"Y Iwakura","year":"2016","unstructured":"Iwakura Y, Ito S, Morimoto R, Kudo M, Ono Y, Nezu M, et al. Renal resistive index predicts postoperative blood pressure outcome in primary aldosteronism. Hypertension. 2016;67:654\u201360.","journal-title":"Hypertension"},{"key":"126_CR23","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1530\/EJE-15-0450","volume":"173","author":"G Hanslik","year":"2015","unstructured":"Hanslik G, Wallaschofski H, Dietz A, Riester A, Reincke M, Allolio B, et al. Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry. Eur J Endocrinol. 2015;173:665\u201375.","journal-title":"Eur J Endocrinol"},{"key":"126_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11845-013-1007-x","volume":"183","author":"W Chen","year":"2014","unstructured":"Chen W, Li F, He C, Zhu Y, Tan W. Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism: a meta-analysis. Ir J Med Sci. 2014;183:283\u201391.","journal-title":"Ir J Med Sci"},{"key":"126_CR25","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1507\/endocrj.EJ13-0060","volume":"60","author":"K Murase","year":"2013","unstructured":"Murase K, Nagaishi R, Takenoshita H, Nomiyama T, Akehi Y, Yanase T. Prevalence and clinical characteristics of primary aldosteronism in Japanese patients with type 2 diabetes mellitus and hypertension. Endocr J. 2013;60:967\u201376.","journal-title":"Endocr J"},{"key":"126_CR26","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/HYPERTENSIONAHA.114.05001","volume":"65","author":"T Matsumoto","year":"2015","unstructured":"Matsumoto T, Oki K, Kajikawa M, Nakashima A, Maruhashi T, Iwamoto Y, et al. Effect of aldosterone-producing adenoma on endothelial function and Rho-associated kinase activity in patients with primary aldosteronism. Hypertension. 2015;65:841\u20138.","journal-title":"Hypertension"},{"key":"126_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/BF03349173","volume":"29","author":"S Zacharieva","year":"2006","unstructured":"Zacharieva S, Orbetzova M, Elenkova A, Stoynev A, Yaneva M, Schigarminova R, et al. Diurnal blood pressure pattern in patients with primary aldosteronism. J Endocrinol Invest. 2006;29:26\u201331.","journal-title":"J Endocrinol Invest"},{"key":"126_CR28","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/cen.12998","volume":"84","author":"H Kobayashi","year":"2016","unstructured":"Kobayashi H, Haketa A, Ueno T, Suzuki R, Aoi N, Ikeda Y, et al. Subtype prediction in primary aldosteronism: measurement of circadian variation of adrenocortical hormones and 24-h urinary aldosterone. Clin Endocrinol (Oxf). 2016;84:814\u201321.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"126_CR29","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1210\/jc.2017-01774","volume":"103","author":"H Umakoshi","year":"2018","unstructured":"Umakoshi H, Tsuiki M, Takeda Y, Kurihara I, Itoh H, Katabami T, et al. Significance of computed tomography and serum potassium in predicting subtype diagnosis of primary aldosteronism. J Clin Endocrinol Metab. 2018;103:900\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"126_CR30","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/jhh.2014.20","volume":"28","author":"K Nanba","year":"2014","unstructured":"Nanba K, Tsuiki M, Nakao K, Nanba A, Usui T, Tagami T, et al. A subtype prediction score for primary aldosteronism. J Hum Hypertens. 2014;28:716\u201320.","journal-title":"J Hum Hypertens"},{"key":"126_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41371-017-0015-0","volume":"32","author":"Y Fujii","year":"2017","unstructured":"Fujii Y, Umakoshi H, Wada N, Ichijo T, Kamemura K, Matsuda Y, et al. Subtype prediction of primary aldosteronism by combining aldosterone concentrations in the left adrenal vein and inferior vena cava: a multicenter collaborative study on adrenal venous sampling. J Hum Hypertens. 2017;32:12\u20139.","journal-title":"J Hum Hypertens"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0126-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0126-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0126-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:19:41Z","timestamp":1684617581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-018-0126-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,6]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["126"],"URL":"https:\/\/doi.org\/10.1038\/s41440-018-0126-1","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,6]]},"assertion":[{"value":"5 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, received research grants from Bristol-Myers Squibb, MSD K.K., Pfizer Japan Inc., Takeda Pharmaceutical Co., Ltd., Astellas Pharma Inc., Daiichi Sankyo Pharmaceutical Co., Ltd., Genzyme Japan, Shionogi & Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Mitsubishi Tanabe Corporation, Otsuka Pharmaceutical Co., Ltd., Bayer Yakuhin, Ltd., AstraZeneca K.K., and Boehringer Ingelheim Co., Ltd. Masaaki Ito received lecture fees from Daiichi Sankyo Co. Pharmaceutical Co., Ltd., Mitsubishi Tanabe Corporation, Bayer Yakuhin, Ltd. and Takeda Pharmaceutical Co., Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}